First Trust NYSE Arca Biotechnology Index Fund
0
Funds holding %
of 7,334 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
6,906% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $34K
121% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 14
4% more funds holding
Funds holding: 255 [Q4 2024] → 266 (+11) [Q1 2025]
0.83% more ownership
Funds ownership: 51.36% [Q4 2024] → 52.2% (+0.83%) [Q1 2025]
7% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 84
48% less capital invested
Capital invested by funds: $1.1B [Q4 2024] → $577M (-$525M) [Q1 2025]
100% less funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 0 (-1) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for FBT.
Financial journalist opinion
Neutral
Zacks Investment Research
1 month ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Launched on 06/19/2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
1 month ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on 06/19/2006.
Neutral
Seeking Alpha
2 months ago
Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Positive
Seeking Alpha
2 months ago
FBT: This 30-Stock Biotech ETF Isn't Worth The Risk Today
FBT selects 30 biotechnology stocks based on sales, sales as a percentage of R&D expenditures, and R&D growth compared to three years ago. The ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector, despite its high 0.56% expense ratio. A closer look at performance reveals that FBT is subject to periods of significant gains and losses, though it has struggled over the last five and ten-year periods.
Neutral
Zacks Investment Research
3 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund launched on 06/19/2006.
Neutral
Zacks Investment Research
3 months ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.
Neutral
Seeking Alpha
5 months ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Neutral
Zacks Investment Research
5 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
5 months ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on 06/19/2006.
Neutral
Zacks Investment Research
7 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.
Charts implemented using Lightweight Charts™